Improving cardiovascular health in the German CINDI area: Methods and results of the practice-based Three-Level Strategy (CINDI equals; Countrywide integrated noncommunicable diseases intervention programme of the WHO)

European Journal of General Practice

Volumn 2, Issue 3, 1996, Pages 117-125

  Wiesemann, Armin ^a   Nassel, Egbert ^b   Scheuermann, Wolfgang ^a   Topf, Gunter ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Max Planck Strae 8   (Germany)

^c University of Heidelberg ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007704902     PISSN: 13814788     EISSN: 17511402     Source Type: Journal    
DOI: 10.3109/13814789609161542     Document Type: Article

References (36)

1. McGinnis JM. Targeting progress in health. Public Health Reports 1987; 97: 295-307.
2. Klimm HD. Früherkennung und Häufigkeit der peripheren arteriellen Verschlulßkrankheit in der Allgemeinpraxis. Nürnberg: PIA-Verlagsgesellschaft, 1991.
3. Wiesemann A, Klimm HD, Nüssel E. Das Östringer (Praeventions-) Modell: Ergebnisse hausärztlich verantworteter 'gemeindebezogener Verhaltensmedizin'. Z ärztl Fortbild 1996; 90: 59-66. (Pubitemid 126774558)
4. Derby CA, Lasater TM, Feldman HA, Carleton RA. Adverse risk factors trends in the Pawtucket Heart Health Program communities: increasing BMI and declining HDL: Abstract 21. In: International Workshop on Cardiovascular Diseases: Prevention and Epidemiology. Wildbad-Kreuth: GSF, Projekttrager des BMFT, 1994.
5. Feldman HA, Winkleby MA, Murray DM. Cross-sectional synthesis of effect of three US community based intervention trials for reduction of cardiovascular risk: Abstract 1. In: International Workshop on Cardiovascular Diseases: Prevention and Epidemiology. WildbadKreuth: GSF, Projekttrager des BMFT, 1994.
6. Nissinen A, Tuomiletho J, Kottke, TE, Puska P. Cost-effectiveness of the North Karelia Hypertension Programme 1972-1977. Med Care 1986; 24: 767-80.
7. Farquhar JW, Fortmann SP, Flera JA, Taylor JB, Haskell WL, Williams PT, et al. Effects of community wide education on cardiovascular risk factors. The Stanford Five-City Project. J Am Med Ass 1990; 264: 359-65. (Pubitemid 20219283)
8. Bergdolt H. Gesundheitsvorsorge fur Herz und Kreislauf. Wieslocher Modell. Ilvesheim: Muller Druck, 1977.
9. Nüssel E. Community-based prevention: the Eberbach-Wiesloch Study: 50-59. In: Primary and secondary prevention of coronary heart disease. Berlin Heidelberg New York: Hofmann H Springer, 1985.
10. Scheuermann W, Scheidt R, Nüssel E, Wiesemann A. Health promotion tomorrow and the transformation of the practice of medicine. Health Prom Internat 1990; 1: 45-56. (Pubitemid 20251553)
11. Wiesemann A, Morgenstern W, Nüssel E, Topf G. Considerations on quality assurance in community related behavioural medicine of the Östringen Model: 341-52. In: Laaser U, Leeuw, Stock C, editors. Juventa, Weinheim: Scientific Foundations for a Public Health Policy in Europe, 1995 .
12. Hoffmeister H, Mensink GBM, Stolzenberg H. National trend in risk factors for cardiovascular disease in Germany. Prev Med 1994; 23: 197-205. (Pubitemid 24177861)
13. WHO Regional Bureau for Europe Copenhagen, editor. The role of the general practioner in the CINDI Programme. Report on a meeting, Heidelberg 11. -13. April 1991. Copenhagen: WHO, 1991.
14. Leparski E, Nüssel E. CINDI Countrywide Integrated Non-Communicable Diseases Intervention programme, WHO Protocol and Guidelines for Monitoring and Evaluation Procedures. Berlin Heidelberg New York: Springer, 1987.
15. Wiesemann A, Nüssel E, Scheuermann W. Health status models as tools to translate research results into policy: The Prevention Model of Östringen. Can J Cardiol 1993; 9S: 130-2.
16. Murray SA, Graham LJC. Practice based health needs assessment: use of four methods in a small neighbourhood. Br Med J 1995; 310: 1443-8.
17. Basler H-D, Unnewehr S, Gluth G. Follow-up of a group treatment for obese essential hypertensives in a primary care setting. Patient Ed Couns 1991; 17: 217-26.
18. Basler HD, Baumann H, Beckers HH, et al. Beinflussung des Risikoprofils von adipösen essentiellen Hypertonikern durch das Gruppenprogramm 'Hypertonie im Gesprach'. Soz Präv Med 1988; 1: 46-50.
19. Ornish D, Brown SE, Scherwitz LW, Billing JH, Armstrong WT, Ports TA, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129-33. (Pubitemid 20224971)
20. Donabedian A. Explorations in quality assessment and monitoring. Vol. 1: The definition of quality and approaches to its assessment. Ann Arbor: Health Administration Press, 1980.
21. Wiesemann A, Fay K, Scheidt R, Scheuermann W. What can general practitioners contribute to health promotion in schools? Soz Präv Med 1996; 41: 79-89. (Pubitemid 26168849)
22. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. Br Med J 1994; 308: 313-20.
23. Paffenbarger RSjr, Hyde RT, Wing AL, Lee EM, Jung DL, Kampert JB. The association of changes in physical-activity level and other life style chracteristics with mortality among men. N Engl J Med 1993; 328: 538-45. (Pubitemid 23053830)
24. Fries JF. Strategies for reduction of morbidity. Am] Clin Nutr 1992; 55: 1257S-62S.
25. Field K, Thorogood M, Silagy C, Normand C, O'Neill C, Muir J. Strategies for reducing coronary risk factors in primary care: which is most cost effective? Br Med J 1995; 310: 1109-12.
26. Hjalmarsson AIM. Effect of nicotine chewing gum in smoking cessation: a randomized, placebocontrolled, double-blind study, J Amer Med Ass 1984; 225: 2835-8.
27. Brinkmeier U, Basler HD, Buser K. KHK im Gespräch - ein verhaltenstherapeutisch orientiertes Gruppenprogramm für koronar- gefährdete Raucher. In: Basler HD, editor. Gruppenarbeit in der Allgemeinpraxis, 65-95. Berlin Heidelberg New York: Springer, 1989.
28. Gibbins RL, Riley M, Brimble P. Effectivness of programme of reducing cardiovascular risk for men in one general practice. Br Med J 1993; 306: 1652-6. (Pubitemid 23168398)
29. Keul J, Lehmann M, Dickhuth HH. Hypertonie, Herz und körperliche Aktivität. Z Kardiol 1989; 78 Suppl 7: 199-209.
30. Blair SM, Kohl HW, Gordon NF, Paffenbarger RSjr. How much physical activity is good for health? Annu Rev Public Health 1992; 3: 99-126.
31. Luepker RV. Community trials. Prev Med 1994; 23: 602-5. (Pubitemid 24377870)
32. Klesges RC, Meyers AW, Winders SE. Determining the reasons for weight gain following smoking cessation: current findings, methodological issues, and future directions for research. Ann Behav Med 1989; 11: 134-43. (Pubitemid 20110603)
33. Sheperd J, Cobbe MS, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1302-7.
34. Rose G. Sick Individuals and sick populations. Int J Epidem 1985; 1: 32-8. (Pubitemid 15109489)
35. Grol R, Drenth B, Zwaard T. The use of facilitators in quality improvement. In: Grol R, Wensing M, Jacobs A, Baker R, editors. Quality assurance in general practice, the state of the art in Europe. Utrecht: NHG, 1993.
36. Abholz HH. Screening for cardiovascular risks - in whose interest do we act? Eur J Gen Pract 1995; 1: 101-2.